(Q45354182)

13 December 2017

title

Risk stratification for hepatitis B virus related hepatocellular carcinoma (English)

1 reference

13 December 2017

1 reference

1 reference

Chih-Lin Lin

1

1 reference

13 December 2017

Jia-Horng Kao

series ordinal

2

1 reference

13 December 2017

publication date

1 January 2013

1 reference

Journal of Gastroenterology and Hepatology

13 December 2017

published in

1 reference

13 December 2017

volume

28

1 reference

13 December 2017

issue

1

1 reference

13 December 2017

page(s)

10-17

1 reference

Global control of hepatitis B virus infection.

13 December 2017

cites work

1 reference

Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspects

21 January 2018

1 reference

Hepatitis B virus genotypes and hepatocellular carcinoma in Taiwan.

21 January 2018

1 reference

Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.

21 January 2018

1 reference

Predicting cirrhosis risk based on the level of circulating hepatitis B viral load

21 January 2018

1 reference

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

21 January 2018

1 reference

The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B

21 January 2018

1 reference

Geographical and genetic diversity of the human hepatitis B virus

21 January 2018

1 reference

Clinical relevance and public health significance of hepatitis B virus genomic variations

21 January 2018

1 reference

Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers

21 January 2018

1 reference

Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection

21 January 2018

1 reference

Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C.

21 January 2018

1 reference

Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B

21 January 2018

1 reference

Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.

21 January 2018

1 reference

Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study.

21 January 2018

1 reference

Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.

21 January 2018

1 reference

Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma

21 January 2018

1 reference

Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma

21 January 2018

1 reference

Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area

21 January 2018

1 reference

Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B.

21 January 2018

1 reference

Precore/basal core promoter mutants and hepatitis B viral DNA levels as predictors for liver deaths and hepatocellular carcinoma

21 January 2018

1 reference

Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers

21 January 2018

1 reference

Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study.

21 January 2018

1 reference

Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis

21 January 2018

1 reference

Hepatitis B defective virus with rearrangements in the preS gene during chronic HBV infection

21 January 2018

1 reference

Replicating and virion secreting hepatitis B mutant virus unable to produce preS2 protein

21 January 2018

1 reference

Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection

21 January 2018

1 reference

Hypermodification and immune escape of an internally deleted middle-envelope (M) protein of frequent and predominant hepatitis B virus variants

21 January 2018

1 reference

Ground glass hepatocytes contain pre-S mutants and represent preneoplastic lesions in chronic hepatitis B virus infection.

21 January 2018

1 reference

Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage

21 January 2018

1 reference

Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma

21 January 2018

1 reference

Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients

21 January 2018

1 reference

Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study

21 January 2018

1 reference

Mapping of immunodominant B-cell epitopes and the human serum albumin-binding site in natural hepatitis B virus surface antigen of defined genosubtype.

21 January 2018

1 reference

High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases

21 January 2018

1 reference

Fine mapping of hepatitis B virus pre-S deletion and its association with hepatocellular carcinoma.

21 January 2018

1 reference

The genome of hepatitis B virus

21 January 2018

1 reference

Hepatitis B virus replication

21 January 2018

1 reference

Immunogenicity of the gene S and Pre-S domains in hepatitis B virions and HBsAg filaments

21 January 2018

1 reference

Hepatitis B virus gene function: the precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen

21 January 2018

1 reference

Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: A review

21 January 2018

1 reference

Molecular diagnosis of viral hepatitis

21 January 2018

1 reference

Chronic hepatitis B: update 2009

21 January 2018

1 reference

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

21 January 2018

1 reference

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

21 January 2018

1 reference

Natural history of chronic hepatitis B REVEALed

21 January 2018

1 reference

Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters.

21 January 2018

1 reference

Lower serum viral loads in young patients with hepatitis-B-virus-related hepatocellular carcinoma

21 January 2018

1 reference

Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report

21 January 2018

1 reference

The role of quantitative hepatitis B serology in the natural history and management of chronic hepatitis B

21 January 2018

1 reference

Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response.

21 January 2018

1 reference

Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers

21 January 2018

1 reference

Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.

21 January 2018

1 reference

Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B.

21 January 2018

1 reference

Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.

21 January 2018

1 reference

Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.

21 January 2018

1 reference

Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load

21 January 2018

1 reference

High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load

21 January 2018

1 reference

Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death

21 January 2018

1 reference

Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads

21 January 2018

1 reference

How to predict HCC development in patients with chronic B viral liver disease?

21 January 2018

1 reference

Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers.

21 January 2018

1 reference

Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection

21 January 2018

1 reference

Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score.

21 January 2018

1 reference

Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.

21 January 2018

1 reference

Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study

21 January 2018

1 reference

Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JGH.12010

1 reference

release_5iby6xvp4zfwrigc5jivhrikae

13 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5iby6xvp4zfwrigc5jivhrikae

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference